Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NXGL
NXGL logo

NXGL Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Nexgel Inc (NXGL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.550
1 Day change
1.85%
52 Week Range
2.890
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

NXGL is not a good buy right now for a Beginner with a long-term focus and $50,000-$100,000 to invest. The stock is trading below the previous close, has no strong proprietary buy signal, no recent news catalyst, neutral insider/hedge fund activity, and bearish moving averages. While MACD is slightly positive and the near-term pattern suggests a possible short-term bounce, the overall setup is not strong enough to justify an immediate long-term buy for an impatient investor.

Technical Analysis

Price closed at 0.5432 after a decline from 0.5646, with regular market performance still weak and post-market also negative. MACD histogram is slightly positive and expanding, which supports a mild short-term momentum improvement. RSI at 56.867 is neutral, showing no clear overbought or oversold condition. However, the moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, confirming the broader trend is still weak. Key levels: pivot 0.557, resistance 0.62 and 0.659, support 0.494 and 0.455. Overall, the chart is mixed to bearish, with only modest short-term recovery signs.

Positive Catalysts

  • No news in recent week. The only mild positive is the technical MACD reading, which is above zero and expanding, plus the modeled pattern outlook showing a possible 11.64% move higher over the next month. Intellectia Proprietary Trading Signals: No signal on given stock today.

Neutral/Negative Catalysts

  • No recent news catalyst, neutral hedge fund and insider activity, no recent congress trading data, and no AI Stock Picker or SwingMax entry signal. The stock is also below the pivot level and below key moving averages, which keeps the broader trend weak.

Financial Performance

No usable latest-quarter financial snapshot was provided, so quarterly growth trends cannot be assessed. The provided data does not include the latest quarter season or financial results.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no evidence of a recent bullish or bearish Wall Street revision. Based on the available information, analysts appear neutral by default due to the absence of rating momentum.

Wall Street analysts forecast NXGL stock price to rise
Analyst Rating
0
Wall Street analysts forecast NXGL stock price to rise
Buy
Hold
Sell
0
Current: 0.540
sliders
Low
0
Averages
0
High
0
0
Current: 0.540
sliders
Low
0
Averages
0
High
0
Maxim
Maxim
Buy
downgrade
$6 -> $2
AI Analysis
2026-03-12
Reason
Maxim
Maxim
Price Target
$6 -> $2
AI Analysis
2026-03-12
downgrade
Buy
Reason
Maxim lowered the firm's price target on NexGel to $2 from $6 and keeps a Buy rating on the shares. The company's Celularity acquisition could be transformative for NexGel and turn it into a profitable entity, however the firm is adjusting its price target to reflect the dilution related to the financing for the deal, the analyst tells investors in a research note.

People Also Watch